Effectiveness of GentleWave System in Endodontic Treatment
Launched by UNIVERSITY OF SALAMANCA · Jul 18, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new treatment method called the GentleWave® System to see how well it helps reduce pain after root canal procedures compared to traditional methods. The study will involve patients who have infections in their teeth or need additional treatment after a previous root canal. Researchers want to find out if using the GentleWave® System can make the recovery process easier for patients.
To be eligible for this trial, participants need to be adults aged between 18 and 80 who require endodontic treatment, which is a procedure that helps save teeth affected by infection. Both men and women can participate, whether or not they currently have symptoms. If you join the study, you’ll receive care for your dental issues and be part of a process that may help improve treatment for future patients. It's important to know that some people, like those under 18 or with certain dental issues like fractured teeth or those needing extraction, will not be able to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female patients from 18 years age or older (maximum of 80 years of age), both genders.
- • The patients in need of an endodontic intervention.
- • All dental groups in both arches were eligible.
- • Patients who do or do not experience symptoms after the endodontic intervention.
- • Patient-signed informed consent/assent form
- Exclusion Criteria:
- • Patients\< 18 years old.
- • fractured teeth.
- • Patients who were recommended extraction after the endodontic evaluation.
About University Of Salamanca
The University of Salamanca, one of the oldest and most prestigious universities in Spain, is a leading institution in academic research and clinical trials. With a strong commitment to advancing healthcare and medical science, the university engages in innovative research initiatives that address critical health challenges. Its clinical trial programs are characterized by rigorous scientific methodology, interdisciplinary collaboration, and a focus on ethical standards, ensuring high-quality outcomes that contribute to the advancement of medical knowledge and patient care. The University of Salamanca fosters partnerships with healthcare professionals and industry leaders, positioning itself at the forefront of clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manhattan, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported